159 related articles for article (PubMed ID: 20096934)
21. HLA-E: strong association with beta2-microglobulin and surface expression in the absence of HLA class I signal sequence-derived peptides.
Lo Monaco E; Sibilio L; Melucci E; Tremante E; Suchànek M; Horejsi V; Martayan A; Giacomini P
J Immunol; 2008 Oct; 181(8):5442-50. PubMed ID: 18832701
[TBL] [Abstract][Full Text] [Related]
22. HLA serology--1983.
Grumet FC
Prog Clin Biol Res; 1984; 149():207-20. PubMed ID: 6204338
[No Abstract] [Full Text] [Related]
23. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens.
Duquesnoy RJ; Marrari M
Tissue Antigens; 2009 Aug; 74(2):117-33. PubMed ID: 19497041
[TBL] [Abstract][Full Text] [Related]
24. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
Sumitran-Karuppan S; Möller E
Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
[TBL] [Abstract][Full Text] [Related]
25. Recognition of HLA class I-restricted beta-cell epitopes in type 1 diabetes.
Ouyang Q; Standifer NE; Qin H; Gottlieb P; Verchere CB; Nepom GT; Tan R; Panagiotopoulos C
Diabetes; 2006 Nov; 55(11):3068-74. PubMed ID: 17065344
[TBL] [Abstract][Full Text] [Related]
26. Epitopes of the HLA-A, B, C, DR, DQ and MICA antigens.
El-Awar N; Terasaki PI; Cai J; Deng CT; Ozawa M; Nguyen A
Clin Transpl; 2007; ():175-94. PubMed ID: 18637469
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibody that distinguishes between a phosphorylated, beta 2-microglobulin-associated, and a free, nonphosphorylated, chain of MHC class I.
Thor G; Sepulveda H; Chada S; Dutton RW
J Immunol; 1993 Jul; 151(1):211-24. PubMed ID: 7686933
[TBL] [Abstract][Full Text] [Related]
28. Changes in conformation with loss of alloantigenic determinants of a histocompatibility antigen (HLA-B7) induced by monoclonal antibodies.
Parham P
J Immunol; 1984 Jun; 132(6):2975-83. PubMed ID: 6202768
[TBL] [Abstract][Full Text] [Related]
29. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques.
Piazza A; Poggi E; Ozzella G; Borrelli L; Monaco PI; Scornajenghi A; Tisone G; Adorno D
Transplantation; 2006 May; 81(9):1298-305. PubMed ID: 16699458
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibodies to HLA-E bind epitopes carried by unfolded β2 m-free heavy chains.
Tremante E; Lo Monaco E; Ingegnere T; Sampaoli C; Fraioli R; Giacomini P
Eur J Immunol; 2015 Aug; 45(8):2356-64. PubMed ID: 25982269
[TBL] [Abstract][Full Text] [Related]
31. Absence of cell surface fixation of a monoclonal antibody detectable by conventional immunoassays does not exclude expression of and interaction with the corresponding antigenic determinant.
Layet C; Le Bouteiller PP; Olive D; Mishal Z; Caillol D; Kourilsky FM; Jordan BR; Lemonnier FA
Eur J Immunol; 1984 Jan; 14(1):99-102. PubMed ID: 6198185
[TBL] [Abstract][Full Text] [Related]
32. Acquisition of HLA class I W6/32 defined antigenic determinant by heavy chains from different species following association with bovine beta 2-microglobulin.
Kahn-Perles B; Boyer C; Arnold B; Sanderson AR; Ferrier P; Lemonnier FA
J Immunol; 1987 Apr; 138(7):2190-6. PubMed ID: 2435790
[TBL] [Abstract][Full Text] [Related]
33. A monoclonal antibody directed against the HLA-Bw6 epitope.
Radka SF; Kostyu DD; Amos DB
J Immunol; 1982 Jun; 128(6):2804-6. PubMed ID: 6176653
[TBL] [Abstract][Full Text] [Related]
34. Structural relatedness of distinct determinants recognized by monoclonal antibody TP25.99 on beta 2-microglobulin-associated and beta 2-microglobulin-free HLA class I heavy chains.
Desai SA; Wang X; Noronha EJ; Zhou Q; Rebmann V; Grosse-Wilde H; Moy FJ; Powers R; Ferrone S
J Immunol; 2000 Sep; 165(6):3275-83. PubMed ID: 10975844
[TBL] [Abstract][Full Text] [Related]
35. Transformation of murine LMTK- cells with purified HLA class I genes. I. Modification of conformation of murine beta 2-microglobulin upon its association with HLA heavy chains.
Lemonnier FA; Le Bouteiller PP; Malissen B; Golstein P; Malissen M; Mishal Z; Caillol DH; Jordan BR; Kourilsky FM
J Immunol; 1983 Mar; 130(3):1432-8. PubMed ID: 6185587
[TBL] [Abstract][Full Text] [Related]
36. [Current status of research on specific monoclonal xenoantibodies against human histocompatibility antigens].
Crepaldi T
G Batteriol Virol Immunol; 1980; 73(7-12):145-57. PubMed ID: 7030844
[No Abstract] [Full Text] [Related]
37. Cell-surface expression and alloantigenic function of a human nonclassical class I molecule (HLA-E) in transgenic mice.
Pacasova R; Martinozzi S; Boulouis HJ; Ulbrecht M; Vieville JC; Sigaux F; Weiss EH; Pla M
J Immunol; 1999 May; 162(9):5190-6. PubMed ID: 10227992
[TBL] [Abstract][Full Text] [Related]
38. Production and characterization of monoclonal antibodies with specificity for human HLA-G isoforms.
Yari F; Hosseini AZ; Nemat-Gorgani M; Sareh S; Khorramizadeh MR; Mansouri P; Nejad AK
Hybrid Hybridomics; 2003 Oct; 22(5):301-6. PubMed ID: 14678647
[TBL] [Abstract][Full Text] [Related]
39. HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity.
Weiss EH; Lilienfeld BG; Müller S; Müller E; Herbach N; Kessler B; Wanke R; Schwinzer R; Seebach JD; Wolf E; Brem G
Transplantation; 2009 Jan; 87(1):35-43. PubMed ID: 19136889
[TBL] [Abstract][Full Text] [Related]
40. First report on the antibody verification of HLA-ABC epitopes recorded in the website-based HLA Epitope Registry.
Duquesnoy RJ; Marrari M; Mulder A; Sousa LC; da Silva AS; do Monte SJ
Tissue Antigens; 2014 Jun; 83(6):391-400. PubMed ID: 24828056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
